A detailed history of Wealth Advisory Solutions, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Advisory Solutions, LLC holds 151,000 shares of CTXR stock, worth $80,030. This represents 0.04% of its overall portfolio holdings.

Number of Shares
151,000
Holding current value
$80,030
% of portfolio
0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$0.6 - $0.9 $90,600 - $135,900
151,000 New
151,000 $135,000
Q3 2023

Feb 07, 2024

BUY
$0.65 - $1.25 $100,184 - $192,662
154,130 New
154,130 $104,000
Q4 2022

Feb 10, 2023

SELL
$0.79 - $1.23 $790 - $1,230
-1,000 Reduced 0.64%
155,850 $123,000
Q2 2021

Jul 21, 2021

BUY
$1.51 - $4.23 $75,500 - $211,500
50,000 Added 46.79%
156,850 $546,000
Q1 2021

May 13, 2021

BUY
$1.04 - $2.34 $1,040 - $2,340
1,000 Added 0.94%
106,850 $0
Q4 2020

Jan 28, 2021

BUY
$0.9 - $1.2 $95,265 - $127,020
105,850 New
105,850 $107,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $77.4M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Wealth Advisory Solutions, LLC Portfolio

Follow Wealth Advisory Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Advisory Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Advisory Solutions, LLC with notifications on news.